We are thrilled to announce that Valerie has successfully raised $3,500,000 in our latest funding round, a testament to our unwavering commitment to revolutionizing healthcare for the one billion women navigating the complexities of peri/menopause. At Valerie, our mission is to empower women to embrace this pivotal stage of life with confidence and vigor. Our innovative product, Daily Essential, harnesses pioneering liposomal nanotechnology to provide an extraordinary 76 health benefits, addressing a wide spectrum of symptoms that often accompany this transition. Gone are the days of silently seeking relief; with Valerie, we encourage women to reclaim their health and joy, and to truly embrace midlife as “maxlife.” This funding will enable us to enhance our product offerings, expand our reach, and continue to educate women about their health during this crucial time. With the support of our investors, we are just getting started on this journey and are excited to build a future where every woman feels empowered and informed in managing her health. We invite health-conscious investors and interested parties to connect with us to explore our pre-seed deck, which is eligible for both SEIS and EIS. Join us as we embark on this transformative journey, turning whispers for relief into a resounding shout for change in women's healthcare. Together, we can pave the way for a healthier, more vibrant future for women everywhere.







